Compare iShares Core Growth Allocation ETF (AOR) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core Growth Allocation ETF vs Xylem, Inc. — how do they compare? iShares Core Growth Allocation ETF trades at $68.72, while Xylem, Inc. trades at $121.21 (market cap $28.81B). The key difference: Xylem, Inc. pays a 1.42% dividend while iShares Core Growth Allocation ETF pays none, and iShares Core Growth Allocation ETF is trading nearer its 52-week high, Xylem, Inc. nearer its low. Which is the better fit depends on your goals.
| AOR | XYL | |
|---|---|---|
52-Week High | $69.85 | $152.95 |
52-Week Low | $61.00 | $106.34 |
Market Cap | — | $28.81B |
Sector | — | Industrials |
Enterprise Value | — | $30.07B |
Dividend Yield | — | 1.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The iShares Core Growth Allocation ETF (AOR) trades at $69.10, up 0.25% on the day, with a bearish technical signal from moving averages and neutral oscillators. The fund maintains a fixed 60/40 stock/bond allocation, rebalanced semiannually, with a low 0.20% expense ratio. Recent news highlights its role as a core holding but notes underperformance versus the S&P 500 over a decade.
Outlook: AOR offers diversified, low-cost exposure but faces headwinds from equity-bond correlation shifts. Risks include interest rate sensitivity and competition from pure equity funds. Analyst sentiment is mixed, balancing simplicity against relative returns.
XYL trades at $121.22, up 1.96% with a bullish technical outlook. The stock shows consistent earnings beats, with Q1 2026 EPS of $1.12 exceeding expectations. Revenue grew to $9.04B in 2025, and net income margin improved to 10.79%. Recent news highlights strategic partnerships and leadership appointments, reinforcing growth in water technology solutions. The company maintains a strong balance sheet with total assets of $16.49B and shareholder equity of $10.64B as of 2024.
XYL presents a favorable investment case with analyst consensus price target of $153.14, implying 26% upside. Strengths include steady revenue growth, expanding margins, and positive cash flow trends. Risks involve market volatility and execution challenges in scaling new partnerships. Institutional sentiment is mixed but leans bullish, supported by a 47.5% buy rating from analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Core Growth Allocation ETF
The fund is a fund of funds and seeks its investment objective by investing primarily in underlying funds that themselves seek investment results corresponding to their own respective underlying indexes. It generally will invest at least 80% of its assets in the component securities of its underlying index. The index measures the performance of the S&P Dow Jones Indices LLC proprietary allocation model.
Read more on AOR →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
